Cargando…

The Potential of Drug Delivery Nanosystems for Sepsis Treatment

Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yi, Zhu, Meng-Lu, Wu, Qian, Huang, Yi, Xu, Xiao-Ling, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702780/
https://www.ncbi.nlm.nih.gov/pubmed/34984019
http://dx.doi.org/10.2147/JIR.S339113
_version_ 1784621318907363328
author Shi, Yi
Zhu, Meng-Lu
Wu, Qian
Huang, Yi
Xu, Xiao-Ling
Chen, Wei
author_facet Shi, Yi
Zhu, Meng-Lu
Wu, Qian
Huang, Yi
Xu, Xiao-Ling
Chen, Wei
author_sort Shi, Yi
collection PubMed
description Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, such as rapid metabolism and severe side effects. The emergence of drug delivery nanosystems can significantly improve tissue permeability, prolong drugs’ circulation time, and reduce side effects. In this paper, we reviewed recent drug delivery nanosystems designed for sepsis treatment based on their mechanisms (anti-bacterial, anti-inflammatory, and antioxidant). Although great progress has been made recently, clinical practice transformation is still very difficult. Therefore, we also discussed key obstacles, including tissue distribution, overcoming bacterial resistance, and single treatment modes. Finally, a rigorous optimization of drug delivery nanosystems is expected to present great potential for sepsis therapy.
format Online
Article
Text
id pubmed-8702780
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87027802022-01-03 The Potential of Drug Delivery Nanosystems for Sepsis Treatment Shi, Yi Zhu, Meng-Lu Wu, Qian Huang, Yi Xu, Xiao-Ling Chen, Wei J Inflamm Res Review Sepsis is a major immune response disorder caused by infection, with very high incidence and mortality rates. In the clinic, sepsis and its complications are mainly controlled and treated with antibiotics, anti-inflammatory, and antioxidant drugs. However, these treatments have some shortcomings, such as rapid metabolism and severe side effects. The emergence of drug delivery nanosystems can significantly improve tissue permeability, prolong drugs’ circulation time, and reduce side effects. In this paper, we reviewed recent drug delivery nanosystems designed for sepsis treatment based on their mechanisms (anti-bacterial, anti-inflammatory, and antioxidant). Although great progress has been made recently, clinical practice transformation is still very difficult. Therefore, we also discussed key obstacles, including tissue distribution, overcoming bacterial resistance, and single treatment modes. Finally, a rigorous optimization of drug delivery nanosystems is expected to present great potential for sepsis therapy. Dove 2021-12-19 /pmc/articles/PMC8702780/ /pubmed/34984019 http://dx.doi.org/10.2147/JIR.S339113 Text en © 2021 Shi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Shi, Yi
Zhu, Meng-Lu
Wu, Qian
Huang, Yi
Xu, Xiao-Ling
Chen, Wei
The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title_full The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title_fullStr The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title_full_unstemmed The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title_short The Potential of Drug Delivery Nanosystems for Sepsis Treatment
title_sort potential of drug delivery nanosystems for sepsis treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702780/
https://www.ncbi.nlm.nih.gov/pubmed/34984019
http://dx.doi.org/10.2147/JIR.S339113
work_keys_str_mv AT shiyi thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT zhumenglu thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT wuqian thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT huangyi thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT xuxiaoling thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT chenwei thepotentialofdrugdeliverynanosystemsforsepsistreatment
AT shiyi potentialofdrugdeliverynanosystemsforsepsistreatment
AT zhumenglu potentialofdrugdeliverynanosystemsforsepsistreatment
AT wuqian potentialofdrugdeliverynanosystemsforsepsistreatment
AT huangyi potentialofdrugdeliverynanosystemsforsepsistreatment
AT xuxiaoling potentialofdrugdeliverynanosystemsforsepsistreatment
AT chenwei potentialofdrugdeliverynanosystemsforsepsistreatment